Literature DB >> 27890002

Photosensitizers for Photodynamic Therapy: Photochemistry in the Service of Oncology.

Carsten Lange, Patrick J Bednarski1.   

Abstract

The combined use of a photosensitizing agent, light and dioxygen for the treatment of diseases has become known as photodynamic therapy (PDT) and was first discovered more than one hundred years ago. Over the years, PDT has proven its potential for the treatment of malignant and non-malignant lesions in addition to classical cancer therapy in numerous clinical studies, but application as a routine method is still limited. In this review, the development of modern PDT since the beginning of the twentieth century is briefly portrayed. The underlying mechanisms of phototoxicity are explained, and the requirements for ideal photosensitizers (PS) are underlined. Selected PS are introduced and examples of some of the many attempts made at the optimization of PDT by developing new PS with improved chemical and phototoxic properties, are reviewed. Promising 3rd generation PS are introduced and newer approaches to increasing tumor selectivity and efficacy of PDT, such as with nanoparticles, are discussed. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Photodynamic therapy; photosensitizers; upconversion nanoparticles.

Mesh:

Substances:

Year:  2016        PMID: 27890002     DOI: 10.2174/1381612822666161124155344

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  9 in total

Review 1.  Some Natural Photosensitizers and Their Medicinal Properties for Use in Photodynamic Therapy.

Authors:  Tomasz Piotr Kubrak; Przemysław Kołodziej; Jan Sawicki; Anna Mazur; Katarzyna Koziorowska; David Aebisher
Journal:  Molecules       Date:  2022-02-10       Impact factor: 4.411

2.  On the Pathomorphological Pattern of the Efficiency of Photodynamic Therapy of Murine Melanoma B16 Using a New Photosensitizer Based on Chlorin e6 Conjugate with a Prostate-Specific Membrane Antigen.

Authors:  Olga B Abramova; Grigory A Demyashkin; Valentina V Drozhzhina; Nina D Yakovleva; Ekaterina A Kozlovtseva; Tatiana P Sivovolova; Petr V Shegay; Sergey A Ivanov; Andrey D Kaprin
Journal:  Molecules       Date:  2022-05-26       Impact factor: 4.927

3.  Photodynamic Therapy-Adjunctive Therapy in the Treatment of Prostate Cancer.

Authors:  Michał Osuchowski; David Aebisher; Dorota Bartusik-Aebisher; Magdalena Krupka-Olek; Klaudia Dynarowicz; Maria Przygoda; Aleksandra Kawczyk-Krupka
Journal:  Diagnostics (Basel)       Date:  2022-04-28

Review 4.  Application of photodynamic therapy for liver malignancies.

Authors:  Heng Zou; Fusheng Wang; Jiang-Jiao Zhou; Xi Liu; Qing He; Cong Wang; Yan-Wen Zheng; Yu Wen; Li Xiong
Journal:  J Gastrointest Oncol       Date:  2020-04

5.  New Ru(ii) complex for dual photochemotherapy: release of cathepsin K inhibitor and 1O2 production.

Authors:  Thomas N Rohrabaugh; Kelsey A Collins; Congcong Xue; Jessica K White; Jeremy J Kodanko; Claudia Turro
Journal:  Dalton Trans       Date:  2018-08-29       Impact factor: 4.390

6.  Multifunctionalized biocatalytic P22 nanoreactor for combinatory treatment of ER+ breast cancer.

Authors:  Kanchan Chauhan; Juan M Hernandez-Meza; Ana G Rodríguez-Hernández; Karla Juarez-Moreno; Prakhar Sengar; Rafael Vazquez-Duhalt
Journal:  J Nanobiotechnology       Date:  2018-02-20       Impact factor: 10.435

7.  Fluorinated maleimide-substituted porphyrins and chlorins: synthesis and characterization.

Authors:  Valentina A Ol'shevskaya; Elena G Kononova; Andrei V Zaitsev
Journal:  Beilstein J Org Chem       Date:  2019-11-13       Impact factor: 2.883

8.  Evaluation for Synergistic Effects by Combinations of Photodynamic Therapy (PDT) with Temoporfin (mTHPC) and Pt(II) Complexes Carboplatin, Cisplatin or Oxaliplatin in a Set of Five Human Cancer Cell Lines.

Authors:  Carsten Lange; Patrick J Bednarski
Journal:  Int J Mol Sci       Date:  2018-10-16       Impact factor: 5.923

9.  Synthesis, Characterization and Photodynamic Activity against Bladder Cancer Cells of Novel Triazole-Porphyrin Derivatives.

Authors:  Ana T P C Gomes; Rosa Fernandes; Carlos F Ribeiro; João P C Tomé; Maria G P M S Neves; Fernando de C da Silva; Vítor F Ferreira; José A S Cavaleiro
Journal:  Molecules       Date:  2020-03-31       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.